These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4112126)

  • 41. [Ventricular fibrillation in acute phase of myocardial infarct. 1. Relationship between the development of ventricular fibrillation in myocardial infarct and previous rhythm disorders].
    Raĭskina ME
    Kardiologiia; 1975 Jul; 15(7):83-8. PubMed ID: 54452
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiac vulnerability.
    Surawicz B; Steffens T
    Cardiovasc Clin; 1973; 5(3):159-81. PubMed ID: 4601967
    [No Abstract]   [Full Text] [Related]  

  • 43. [Bretylium tosylate in the treatment and prevention of ventricular arrhythmia: a new look at an old drug].
    Dłuzniewski M
    Pol Tyg Lek; 1988 Oct; 43(44):1415-8. PubMed ID: 3075282
    [No Abstract]   [Full Text] [Related]  

  • 44. Linoleic acid and susceptibility to fatal ventricular fibrillation in rats.
    Logan RL; Larking P; Nye ER
    Atherosclerosis; 1977 Jul; 27(3):265-9. PubMed ID: 901623
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prehospital precursors of ventricular arrhythmias in acute myocardial infarction.
    Moss AJ; Goldstein S; Greene W; DeCamilla J
    Arch Intern Med; 1972 May; 129(5):756-62. PubMed ID: 5025898
    [No Abstract]   [Full Text] [Related]  

  • 46. The effects of calcium entry blockade on the vulnerability of infarcted canine myocardium toward ventricular fibrillation.
    Lynch JJ; Montgomery DG; Lucchesi BR
    J Pharmacol Exp Ther; 1986 Nov; 239(2):340-5. PubMed ID: 3490565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiarrhythmic efficacy of a new class III agent, UK-68,798, during chronic myocardial infarction: evaluation using three-dimensional mapping.
    Zuanetti G; Corr PB
    J Pharmacol Exp Ther; 1991 Jan; 256(1):325-34. PubMed ID: 1988663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ventricular fibrillation.
    Cranefield PF
    N Engl J Med; 1973 Oct; 289(14):732-6. PubMed ID: 4727531
    [No Abstract]   [Full Text] [Related]  

  • 49. Intercellular adhesion molecule 1 (ICAM-1)--a new substrate for the development of ventricular fibrillation?
    Behnes M; Ruff C; Lang S; Kälsch T; Borggrefe M; Elmas E
    Int J Cardiol; 2013 Oct; 168(5):4917-9. PubMed ID: 23972954
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of posterior hypothalamic stimulation on ventricular fibrillation threshold.
    Verrier RL; Calvert A; Lown B
    Am J Physiol; 1975 Mar; 228(3):923-7. PubMed ID: 1115257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Action of triglycerides and non-esterified fatty acids on carbohydrate assimilation in normal dogs].
    Couturier E; Conard V
    C R Seances Soc Biol Fil; 1969; 163(1):225-8. PubMed ID: 4241418
    [No Abstract]   [Full Text] [Related]  

  • 52. Serum-free-fatty-acids and arrhythmiasafter acute myocardial infarction.
    Oliver MF; Kurien VA
    Lancet; 1969 Nov; 2(7629):1077-8. PubMed ID: 4187569
    [No Abstract]   [Full Text] [Related]  

  • 53. The significance of psychological events in a coronary care unit. Preliminary report.
    Theorell T; Wester PO
    Acta Med Scand; 1973 Mar; 193(3):207-10. PubMed ID: 4693784
    [No Abstract]   [Full Text] [Related]  

  • 54. A comparison of the electrical ventricular fibrillation threshold with and without anesthesia.
    McIntosh HD; Starmer F; Whalen RE
    Am Heart J; 1966 Sep; 72(3):419-20. PubMed ID: 5917598
    [No Abstract]   [Full Text] [Related]  

  • 55. Antilipolytic drugs for the prevention of primary ventricular fibrillation.
    Oliver MF
    Diabetes Obes Metab; 2001 Apr; 3(2):61-5. PubMed ID: 11298727
    [No Abstract]   [Full Text] [Related]  

  • 56. Free fatty acids and cardiac arrhythmias.
    Kurien VA; Oliver MF
    Lancet; 1970 Apr; 1(7651):847. PubMed ID: 4191478
    [No Abstract]   [Full Text] [Related]  

  • 57. Fatty acids and ventricular fibrillation threshold.
    Kostis J; Horstmann E
    Lancet; 1972 Apr; 1(7757):961-2. PubMed ID: 4112126
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of high concentrations of free fatty acids on the ventricular fibrillation threshold of normal dogs and dogs with acute myocardial infarction.
    Kostis JB; Mavrogeorgis EA; Horstmann E; Gotzoyannis S
    Cardiology; 1973; 58(2):89-98. PubMed ID: 4750798
    [No Abstract]   [Full Text] [Related]  

  • 59. Free fatty acids and heart-attacks.
    Lancet; 1971 Apr; 1(7704):843-4. PubMed ID: 4102532
    [No Abstract]   [Full Text] [Related]  

  • 60. Failure of high concentrations of circulating free fatty acids to provoke arrhythmias in experimental myocardial infarction.
    Opie LH; Norris RM; Thomas M; Holland AJ; Owen P; van Noorden S
    Lancet; 1971 Apr; 1(7704):818-22. PubMed ID: 4102524
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.